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Abstract
Introduction: CoV infections can potentially cause from a simple 
cold to a severe respiratory syndrome, such as the Severe Acute 
Respiratory Syndrome and the Middle East Respiratory Syndrome 
(MERS-CoV). The COVID-19 created a new reality for global 
healthcare delivery models. 
Objective: To evaluate trends in case-fatality rates of COVID-19 in 
the world. 
Methods: We conducted a population-based time-series study 
using public and official data of cases and deaths from COVID-19 
in Argentina, Australia, Brazil, Chile, China, Colombia, France, 
Germany, India, Iran, Italy, Japan, Mexico, Morocco, New Zealand, 
Nigeria, Peru, Saudi Arabia, South Africa, South Korea, Spain, 
Switzerland, United Kingdom, United States and Russia, between 
December, 2019 and August, 2020. Data were based on reports 
from the European Centre for Disease Prevention and Control. 
COVID-19 was defined according to the International Classification 
of Diseases, 10th revision (U07.1). A Prais-Winsten regression model 
was performed and the Daily Percentage Change (DPC) determined 
rates as increasing, decreasing or flat. 
Results: During the study period, trends in case-fatality rates in the 
world were flat (DPC = 0.3; CI 95% [-0.2: 0.7]; p = 0.225). In Africa, 
Morocco had decreasing trends (DPC = -1.1; CI 95% [-1.5: -0.7]; p 
< 0.001), whereas there were increasing trends in South Africa (p < 
0.05) and flat trends in Nigeria (p > 0.05). In the Americas, Argentina 
showed a decreasing trend in case-fatality rates (DPC = -0.6; CI 95% 
[-1.1: -0.2]; p = 0.005), the U.S. had flat trends (p > 0.05) and all 
other countries in the Americas had increasing trends (p < 0.05). In 
Asia, Iran had decreasing trends (DPC = -1.5; CI 95% [-2.6 : -0.2]; 
p = 0.019); China and Saudi Arabia showed increasing trends (p 
< 0.05), while in India, Japan and South Korea they were flat (p > 
0.05). European countries had mostly increasing trends (p < 0.05): 
Germany, Italy, Spain, the UK and Russia; France and Switzerland 
had flat trends (p > 0.05). Finally, in Oceania, trends in case-fatality 
rates were flat in Australia (p > 0.05) and increasing in New Zealand 
(p < 0.05). 
Conclusion: World trends in case-fatality rates of COVID-19 were 
flat between December 31, 2019 and August 31, 2020. Argentina, 
Iran and Morocco were the only countries with decreasing trends. 
On the other hand, South Africa, Brazil, Canada, Chile, Colombia, 
Mexico, Peru, China, Saudi Arabia, Germany, Spain, United Kingdom, 
Russian and New Zealand had increasing trends in case-fatality 
rates. All the other countries analyzed had flat trends. Based on case-
fatality rate data, our study supports that COVID-19 pandemic is still 
in progress worldwide. 
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The coronaviruses (CoV) are a large family 
of viruses, so named because of surface spikes that 
resemble a crown (corona, Latim)1. The CoV infections 
can potentially cause from a simple cold to a severe 
respiratory syndrome, such as the Severe Acute 
Respiratory Syndrome (SARS-CoV) and the Middle East 
Respiratory Syndrome (MERS-CoV)1,2. The COVID-19 is 
a new variant of the coronaviruses, first isolated in China. 
The novel coronavirus differs from the others because of 
its high impact in public health and the huge number of 
new cases reported in a short time-period2,3. 
The COVID-19 created a new reality for global 
healthcare delivery models1,2. The scientific evidence so far 
available are not enough to meet the demands to face the 
pandemic, since data about specific treatment and vaccines 
are insufficient (WHO)4, which forces governments to 
recommend social distancing as the principal effective 
strategy to contain the spread of the disease. 
Pandemic scenarios require information in order 
to promptly (re)organize health practices and to provide 
health care, such as prevention and treatment, control 
and rehabilitation, since they are essential for health 
care managers and providers5. To address this demand, 
epidemiological studies are relevant to trigger public 
health strategies to control the spread of the virus.
Furthermore, this global scenario suggests that 
nobody can now be protected from an emerging and 
poorly known infectious disease. It would be unwise to 
make specific predictions about the natural history of the 
disease or efforts to contain SARS-CoV-2 outbreaks, but 
it is possible to make some incipient conclusions and to 
protect the most vulnerable from the virus6. 
Health research7 is designed to develop reliable 
data on problems and needs that are important to the 
individual/community, with a particular focus on guiding 
practitioners. In line with that, findings about social 
distancing are probably effective to reduce case-fatality, 
 INTRODUCTION
since they are suitable to prevent and control the extensive 
spread of COVID-198. 
There is a lack of population-based studies assessing 
the trends in case-fatality rates in different countries in 
the world, which is crucial information to understand 
the pandemic dynamic, the severity of the disease and to 
elaborate global public health policies5. The traditional 
cumulative case-fatality rates may possibly underestimate 
the real case-fatality, since each region of the world is 
experiencing a different stage of the pandemic9. Case- 
fatality rates are not static. Rather, they tend to be dynamic 
and change over time. Thus, we aimed to evaluate trends 
in case-fatality rates of COVID-19 around the world.
 METHODS
This a population-based time-series study of public 
and official data available on the website of the European 
Centre for Disease Prevention and Control (https://www.
ecdc.europa.eu/en). 
Data were collected on August 31, 2020, by 
household address for COVID-19 reported cases. 
Population data were extracted from the Country Meters 
website (https://countrymeters.info/en), and included the 
following countries: Argentina (45,757,489 inhabitants), 
Australia (2,5949,452 inhabitants), Brazil (217,040,683 
inhabitants), Chile (18,944,479 inhabitants), China 
(1,410,334,120 inhabitants), Colombia (50,697,280 
inhabitants), France (65,790,781 inhabitants), Germany 
(81,466,451 inhabitants), India (2,195,755,104 
inhabitants), Iran (84,341,761 inhabitants), Italy 
(60,016,386 inhabitants), Japan (125,901,152 inhabitants), 
Mexico (136,136,481 inhabitants), Morocco (36,833,644 
inhabitants), New Zealand (4,695,515 inhabitants), 
Nigeria (208,242,721), Peru (33,538,625 inhabitants), 
Saudi Arabia (35,457,606 inhabitants), South Africa 
(57,581,898), South Korea (51,472,090 inhabitants), 
Spain (45,690,902 inhabitants), Switzerland (8,770,577 
Authors summary 
Why was this study done?
• COVID-19 created a new reality in terms of global healthcare models. 
• The scientific evidence so far available are not enough to meet the demands of the pandemic.
• Epidemiological studies are relevant to trigger public health strategies for spread control.
What did the researchers do and find?
• We conducted a population-based time-series study using public and official data of cases and deaths from COVID-19 in Argentina, 
Australia, Brazil, Chile, China, Colombia, France, Germany, India, Iran, Italy, Japan, Mexico, Morocco, New Zealand, Nigeria, Peru 
(33538625), Saudi Arabia, South Africa, South Korea,  Spain, Switzerland, United Kingdom (UK), United States (U.S.) and Russia, 
between December, 2019 and August, 2020.
• Trends in case-fatality rates were decreasing only in three countries among twenty-six analyzed: Argentina, Iran and Morocco. It was 
more significant in Iran.
• Nigeria, the U.S., India, Japan, South Korea, France, Switzerland and Australia had flat trends in case-fatality rates due to COVID-19.
• All the other countries analyzed in our study had increasing trends in case-fatality rates, with more significant results among countries 
of America and Europe.
What do these findings mean? 
• Increasing trends in case-fatality rates were higher between countries of Americas and Europe, suggesting a greater severity of the 
disease in those continents.
• Decreasing trends in case-fatality rates found in Argentina, Iran and Morocco should attract international attention in order to guide 
public health policies to reduce COVID-19 case-fatality.
• Based on case-fatality data, our study supports that COVID-19 pandemic is still in progress worldwide.
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Statistical analysis
The COVID-19 incidence (new cases / population) 
and mortality (deaths / population) rates were calculated, 
per 1,000,000 inhabitants, and case-fatality (total deaths 
/ total cases) rates, as daily percentage, between January 
and May 2020. 
For trend analyses, we used methods proposed by 
Antunes and Cardoso (2015)10. Time-series rates were 
calculated using a Prais-Winsten regression model, which 
allowed first-order autocorrelation corrections on values by 
time. Thus, the following values were estimated: angular 
coefficient (β) and respective probability (p), considering 
a significance level of 95% confidence interval (CI 95%). 
The data modeling process included transforming 
rates (dependent variable = Y value) into a base 10 
logarithmic function. The independent variable (X value) 
was days of historical series. We also used the Durbin–
Watson test to measure the existence of a first–order 
autocorrelation of the time series of the daily coefficients, 
and to verify if the correlation was compatible with the 
random regression residuals hypothesis11. 
The logarithm rates results (β) of Prais-Winsten 
regression allowed to estimate the Daily Percent Chance 
(DPC) in each country, with the respective confidence 
intervals (95% CI)10: 
inhabitants), United Kingdom (66,679,096 inhabitants), 
United States (333,487,241 inhabitants), and Russia 
(146,590,156 inhabitants). 
The study analyzed cases and deaths reported 
between December 31, 2019 and August 31, 2020. New 
cases and deaths were collected according to day of 
reporting. 
Study population, inclusion and exclusion 
criteria
The World Health Organization assigned the 
emergency ICD-10 code of “U07.1 COVID-19, virus 
identified” to a disease diagnosis of COVID-19 confirmed 
by laboratory testing. 
Data collection started in different dates in each 
country according to the reporting of new cases. In 
Argentina, it started on March 03; in Australia, on January 
25; in Brazil, on January 26; in Canada, on January 26; in 
China, on January 21; in Chile, on March 03; in Colombia, 
on March 07; in France, on January 25; in Germany, on 
January, 28; in India, on January 30; in Iran, on February 
20; in Italy, on January 31; in Japan, on January 21; in 
Mexico, on February 29; in Morocco, on March 03; in 
New Zealand, on February 28; in Nigeria, on February 28; 
in Peru, on March 07; in Saudi Arabia, on March 03; in 
South Africa, on March 06; in South Korea, on January 
21; in Spain, on February 02; in Switzerland, on February 
26; in the United Kingdom, on January 31; in the United 
States, on January 21; and in Russia, on February 01. 
All confirmed cases and deaths of COVID-19 
were included. They were registered according to the 10th 
Revision of the International Classification of Diseases 
(ICD-10) as COVID-19, virus identified (U07.1). 
Data Collection Procedures 
Data were extracted from the public and official 
data system of the European Centre for Disease Prevention 
and Control (ECDC), section “Latest situation update, 
epidemiological curve and global distribution.” The 
ECDC is closely monitoring the outbreak, providing risk 
assessments and public health guidance.
Confirmed cases and deaths were collected from 
national health information systems responsible for 
registering, analyzing and publishing official country 
health data. The data were transferred to the European 
Centre for Disease Prevention and Control, which updated 
it daily. 
Data about the resident population of each country 
was obtained from the Country Meters website and we 
projected population from January to August, 2020. The 
population data account for the total country population as 
of January 01, 2020. 
In order to minimize possible discrepancies, 
the data were extracted by two different researchers 
independently. 
DPC = [–1+10β]*100%
IC 95% = [–1+10βmin]*100%; [–1+10βmax]*100%
This procedure made it possible to determine 
rates as increasing, decreasing or flat, and to quantify 
percent change in daily12 incidence, mortality and case-
fatality rates. The trend was considered to be flat when 
the coefficient was not significantly different from zero (p 
> 0.05). 
To facilitate the visualization of the trends in case- 
fatality rates, we reduced the random variation in the 
graph using the five-order moving average technique11. 
We used the Stata 15.1 statistical software to 
conduct statistical analyses (College Station, TX, U.S. 
2018). 
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Figure 1: Temporal trend of case-fatality rates 
(%) of COVID-19 in the World. December, 2019 - 
August 2020.
Source: Cases and Deaths data from the European Centre for 
Disease Prevention and Control (ECDC). Population data from 
the Country Meters.
Figure 2: Temporal trend of case-fatality (%) 
of COVID-19, according to countries of Africa, 
December, 2019 - August 2020. 
Source: Cases and Deaths data from the European Centre for 
Disease Prevention and Control (ECDC). Population data from 
the Country Meters.
Figure 3: Temporal trend of case-fatality (%) of 
COVID-19, according to countries of Americas, 
December, 2019 - August 2020. 
Source: Cases and Deaths data from the European Centre for 
Disease Prevention and Control (ECDC). Population data from 
the Country Meters.
Figure 4: Temporal trend of case-fatality (%) 
of COVID-19, according to countries of Asia, 
December, 2019 - August 2020. 
Source: Cases and Deaths data from the European Centre for 
Disease Prevention and Control (ECDC). Population data from 
the Country Meters.
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Case-fatality Rates
Between December 31, 2019, and August 3, 2020, 
the case-fatality rate due to COVID-19 in the world was 
3.4%. 
In Africa, among countries analyzed, the highest 
case-fatality rates was found in South Africa (2.2%), 
followed by Nigeria (1.9%) and Morocco (1.8%). Similar 
results were found in Oceania: Australia (2.4%) and New 
Zealand (1.6%) (Table 1).
In the Americas, Mexico had the greatest case-
fatality rate: 10.8%, which represents the fourth country 
with the highest percentage. Canada also showed high 
case-fatality rate: 7.1%. In countries in America, we found 
similar percentages in case-fatality rates, except Chile, 
where it was 0.5%, the lowest rate between all countries 
(Table 1). 
Asia had two different profile of groups: China and 
Iran had case-fatality rates above 5.0%, while the rest of 
Asian countries showed rates below 2.0% (Table 1). 
Europe had the most heterogeneous results 
compared with other continents. Italy, France and United 
Kingdom had case-fatality rates above 10.0%. Spain and 
Switzerland show intermediary rates among European 
countries, while German and Russia were the countries 
with the lowest rates in case-fatality in the continent. 
(Table 1). 
Trends in case-fatality rates
Trends in case-fatality rates in the world were flat 
(DPC = 0.3; CI 95% [-0.2 : 0.7]; p = 0.225) in the study 
period (Table 2, Fig. 1). 
Morocco was one of the three countries in which 
the case-fatality rate was decreasing (DPC = -1.1; CI 95% 
[-1.5 : -0.7]; p < 0.001). In Nigeria, the case-fatality rate 
was flat, while in South Africa it was increasing (Table 2, 
Fig. 2). 
Figure 5: Temporal trend of case-fatality (%) of 
COVID-19, according to countries of Europe, 
December, 2019 - August 2020. 
Source: Cases and Deaths data from the European Centre for 
Disease Prevention and Control (ECDC). Population data from 
the Country Meters.
Figure 6: Temporal trend of case-fatality (%) of 
COVID-19, according to countries of Oceania, 
December, 2019 - August 2020. 
Source: Cases and Deaths data from the European Centre for 
Disease Prevention and Control (ECDC). Population data from 
the Country Meters.
In the Americas, Argentina had decreasing trends 
in case-fatality rates (DPC = -0.6; CI 95% [-1.1: -0.2]; p 
= 0.005), while all other countries had increasing trends. 
The United States, on the other hand, had flat rate trends. 
(Table 2, Fig. 3). 
With regard to Asian countries, Iran showed 
decreasing trends in case-fatality rates (DPC = -1.5; CI 
95% [-2.6: -0.2]; p = 0.019). China and Saudi Arabia had 
increasing trends, while India and South Korea showed 
flat tendency (Table 3, Fig. 4). 
In Europe, France and Switzerland had flat trends 
in case-fatality rates, but all the other countries had 
increasing tendency (Table 3, Fig. 5). 
Finally, in Oceania, Australia had flat tendency, 
while New Zealand had increasing trends in case-fatality 
rates due to COVID-19 (Table 3, Fig 6). 
 DISCUSSION
We estimated trends in case-fatality rates by 
calculating the Daily Percent Change in case-fatality 
rates, which allows the understanding of the dynamic 
of the pandemic better than simply analyzing rates9. 
Between December 31, 2019 and August 31, 2020, trends 
in case-fatality rates due to COVID-19 in the world 
remained flat. Argentina, Iran and Morocco were the only 
countries that had decreasing trends in case-fatality rates. 
Nigeria, United States, India, Japan, South Korea, France, 
Germany, Switzerland and Australia had flat tendency. 
All other countries showed increasing trends, which can 
indicate progressive severity of the disease around the five 
continents. 
Our findings showed case-fatality rates in the world 
similar to Zhao et al. study, who found a rate of 3.1% after 
analyzing 30 studies with 53.000 patients12. Another study 
estimating case-fatality rates showed expected rates for 
this pandemic ranging from 2.9% to 3.0%9. As we already 
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pointed out, case-fatality rates are not static, but rather 
dynamic. Our statistical analyses of world trends suggest 
a flat tendency (p > 0.05). 
Increasing Case-Fatality Rate Trends
South Africa, Brazil, Canada, Chile, Colombia, 
Mexico, Peru, China, Saudi Arabia, Germany, Italy, Spain, 
United Kingdom, Russia and New Zealand had increasing 
trends in case-fatality rates due to COVID-19. Among all 
of them, Canada, Mexico, Peru, Germany, Italy, Spain and 
United Kingdom had case-fatality rates above the world’s 
rate, which can possibly indicate an highest severity of 
the disease in those nations. Germany, Spain and United 
Kingdom showed the greatest Daily Percent Change, 
indicating that Europe still is the continent most affected 
by COVID. 
With regard to Canada, our results contrasts 
with Abdollahi et al. findings, who found a case-fatality 
rate of 1.6% (CI 95% 0.7%–3.1%) on April 22, which 
is significantly lower than ours13. It demonstrates that 
COVID-19 has substantially increased over the past 4 
months. Therefore, it is noteworthy that Canada had a 
high severity of the disease, which is still in progress. 
Regarding Europe, we found the same behavior 
for case-fatality rates pointed by Pachetti et al., who 
described a significant lower rate for Germany (0.31% CI 
95% [0.29; 0.33]) compared to the other nations, on April 
3014. Although the estimation of case-fatality rates are not 
high in Germany, this country had the second increasing 
Daily Percent Change in case-fatality rates among all 26 
countries analyzed. Aside from Germany, Russia had low 
case-fatality rates, but it had also increasing trends. The 
United Kingdom had the highest case-fatality rate and 
upward trend among the nations analyzed in our study. 
Flat Case-Fatality Rate Trends
Nigeria, United States, India, Japan, South Korea, 
France, Switzerland, Australia had flat tendency in case- 
fatality rates due to COVID-19. France and Switzerland 
were the only nations with rates above the world’s, which 
suggests the hypothesis that Europe is not in a regression 
phase of the pandemic. 
With respect to Australia, Chin et al. already noted 
signs that pandemic was under control. They identified 
case-fatality rates raging 0.4% to 3.0%, tending to decrease 
after March 2915. This decrease may be attributed to timely 
implementation and strict enforcement of bans on travel 
and social gatherings, as well as concerted diagnostic and 
management strategies. 
The United States also showed signs of controlling 
the spread of COVID-19. On April 22, Abodollahi et 
al. reported a case-fatality rate of 6.1% (CI 95% 5.4%– 
6.9%)13, which corresponds to approximately twice our 
results. This finding suggests that case-fatality rates might 
have decreased in the previous 4 months and a new flat 
trend emerged. 
Decreasing Case-Fatality Rate Trends
Morocco, Argentina and Iran showed decreasing 
trends ins case-fatality rates of COVID-19. In spite of that, 
Iran was the only country in which case-fatality rates were 
above the estimate of the world’s rate. 
As of May 13, 2020, Ouchetto et al. reported a 
case-fatality rate of 5.26% in Morocco16, almost 3 times 
greatest than our findings, supporting the hypothesis that 
the pandemic is tending toward control in this nation. 
Regarding Iran, we have to interpret the results 
with parsimony, since according to studies, cases reported 
in official statistics at the beginning of the epidemics 
were likely to grossly underestimate the total of actual 
cases. Thus estimating the actual case-fatality rates due to 
COVID-19 is currently impossible17. 
It is important to highlight that our analysis was 
based on public and official secondary data from the 
European Centre for Disease Prevention and Control. 
Even considering unknown underreporting, these are the 
best available data to formulate public health policies. The 
analysis of incidence, mortality, case-fatality rates and 
their respective trends allowed for measurement of risk, 
severity, and magnitude, which are defining indicators to 
understand the dynamics of pandemics6. 
The time-series regression model used in this study 
allowed to estimate the existence the Daily Percent Change 
(DPC) in case-fatality rates, which made it possible to 
measure the dynamic variation of the pandemic among 26 
countries around the five continents worldwide. 
 CONCLUSIONS
Trends in case-fatality rates of COVID-19 in the 
world were flat between December, 31 and August, 31. 
Argentina, Iran and Morocco were the only countries with 
decreasing trends. On the other hand, South Africa, Brazil, 
Canada, Chile, Colombia, Mexico, Peru, China, Saudi 
Arabia, Germany, Spain, United Kingdom, Russian and 
New Zealand had increasing trends in case-fatality rates. 
All other countries analyzed had flat trends. Based on 
case-fatality rates data, our study provides evidence that 
the COVID-19 pandemic is still in progress worldwide. 
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Resumo
Introdução: As infecções por CoV podem causar desde um simples resfriado até uma síndrome 
respiratória grave, como a Síndrome Respiratória Aguda Grave e a Síndrome Respiratória do Oriente 
Médio (MERS-CoV). O COVID-19 impôs uma nova realidade em termos de modelos globais de saúde.
Objetivo: Avaliar as tendências das taxas de letalidade do COVID-19 no mundo.
Método: Estudo de séries temporais de base populacional usando dados públicos e oficiais de casos e 
mortes por COVID-19 na Argentina, Austrália, Brasil, Chile, China, Colômbia, França, Alemanha, Índia, 
Irã, Itália, Japão, México, Marrocos, Nova Zelândia, Nigéria, Peru, Arábia Saudita, África do Sul, Coreia 
do Sul, Espanha, Suíça, Reino Unido, Estados Unidos (EUA) e Rússia, entre dezembro de 2019 e 
agosto de 2020. Os dados foram baseados nos relatórios do Centro Europeu de Prevenção e Controle 
de Doenças. COVID-19 foi definido pela Classificação Internacional de Doenças, 10ª revisão (U07.1). 
Para análise estatística, foi realizada a regressão linear de Prais-Winsten, a partir da qual foi possível 
calcular a variação percentual de mudança diária (DPC) das taxas, classificadas como crescentes, 
decrescentes ou estacionárias.
Resultados: Durante o período do estudo, as taxas de letalidade no mundo permaneceram estacionárias 
(DPC = 0,3; IC 95% [-0,2: 0,7]; p = 0,225). Na África, Marrocos teve tendência decrescente (DPC = -1,1; 
IC 95% [-1,5: -0,7]; p <0,001), enquanto na África do Sul houve tendência crescente (p < 0,05) e estável 
na Nigéria (p> 0,05). Em relação às Américas, a Argentina revelou tendência decrescente nas taxas 
de letalidade (DPC = -0,6; IC 95% [-1,1: -0,2]; p = 0,005), os EUA demonstraram tendência estável (p 
> 0,05) e todos os outros americanos os países demonstraram tendências crescentes (p < 0,05). Na 
Ásia, o Irã apresentou tendência decrescente (DPC = -1,5; IC 95% [-2,6: -0,2]; p = 0,019); China e 
Arábia Saudita apresentaram tendências crescentes (p <0,05), enquanto Índia, Japão e Coreia do Sul 
mantiveram tendência estacionária (p > 0,05). A maioria dos países europeus apresentaram tendências 
crescentes (p <0,05): Alemanha, Itália, Espanha, Reino Unido e Rússia; França e Suíça demonstraram 
tendências estacionárias (p> 0,05). Por fim, na Oceania, a tendência nas taxas de letalidade na Austrália 
foi estável (p > 0,05) e aumentou na Nova Zelândia (p <0,05).
Conclusão: A tendência nas taxas de letalidade por COVID-19 no mundo permaneceu estável entre 
31 de dezembro e 31 de agosto. Argentina, Irã e Marrocos foram os únicos países com tendências 
decrescentes. Por outro lado, África do Sul, Brasil, Canadá, Chile, Colômbia, México, Peru, China, 
Arábia Saudita, Alemanha, Espanha, Reino Unido, Rússia e Nova Zelândia apresentaram tendências 
crescentes de letalidade. Todos os outros países analisados demonstraram tendências estacionárias. 
De acordo com dados de letalidade, nosso estudo confirma que a pandemia de COVID-19 ainda está 
em fase de progressão em todo o mundo.
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